• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care
    Get the next $ALHC alert in real time by email
    SC 13G/A 1 d896517dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G/A

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 2)*

     

     

    Alignment Healthcare, Inc.

    (Name of Issuer)

    Common Stock, $0.01 par value

    (Title of Class of Securities)

    01625V104

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the Appropriate Box to Designate the Rule Pursuant to Which this Schedule Is Filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


     

     1.   

     Names of Reporting Persons

     

     Warburg Pincus Private Equity XII, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     6,520,185

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     6,520,185

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     6,520,185

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     3.40%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     

     1.   

     Names of Reporting Persons

     

     Warburg Pincus Private Equity XII-B, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     1,308,166

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     1,308,166

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     1,308,166

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     0.68%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus Private Equity XII-D, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     188,182

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     188,182

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     188,182

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     0.10%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus Private Equity XII-E, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

    1,074,026

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     1,074,026

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     1,074,026

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     0.56%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     WP XII Partners, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     351,766

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     351,766

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     351,766

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     0.18%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus XII Partners, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     680,454

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     680,454

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     680,454

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     0.35%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus LLC

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     New York

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     10,122,779

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     10,122,779

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     10,122,779

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     5.28%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     OO

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus XII, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     10,122,779

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     10,122,779

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     10,122,779

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     5.28%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     OO

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     WP Global LLC

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     10,122,779

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     10,122,779

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     10,122,779

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     5.28%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus Partners II, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     10,122,779

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     10,122,779

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     10,122,779

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     5.28%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus Partners II Holdings, L.P.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     10,122,779

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     10,122,779

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     10,122,779

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     5.28%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     OO

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus Partners GP LLC

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     10,122,779

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     10,122,779

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     10,122,779

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     5.28%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


     1.   

     Names of Reporting Persons

     

     Warburg Pincus & Co.

     2.  

     Check The Appropriate Box if a Member of a Group (See Instructions)

     

     (a) ☐  (b) ☒

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     New York

    Number of

    Shares Beneficially 

    Owned By

    Each

    Reporting

    Person

    With

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     10,122,779

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     10,122,779

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     10,122,779

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     5.28%(1)

    12.  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    Calculated based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.


    Item 1(a).

    Name of Issuer:

    Alignment Healthcare, Inc. (the “Issuer”)

     

    Item 1(b).

    Address of Issuer’s Principal Executive Offices:

    1100 W. Town and Country Road, Suite 1600

    Orange, CA 92868

     

    Item 2(a).

    Names of Persons Filing:

    This statement is filed by the entities and persons listed below, each of whom is referred to herein as a “Reporting Person” and together as the “Reporting Persons”:

    1. Warburg Pincus Private Equity XII, L.P. (“WP XII”)

    2. Warburg Pincus Private Equity XII-B, L.P. (“WP XII-B”)

    3. Warburg Pincus Private Equity XII-D, L.P. (“WP XII-D”)

    4. Warburg Pincus Private Equity XII-E, L.P. (“WP XII-E”)

    5. WP XII Partners, L.P. (“WP XII Partners”)

    6. Warburg Pincus XII Partners, L.P. (“Warburg Pincus XII Partners,” and, together with WP XII, WP XII-B, WP XII-D, WP XII-E, and WP XII Partners, the “WP XII Funds”)

    7. Warburg Pincus LLC (“WP LLC”), a registered investment adviser and the manager of the WP XII Funds

    8. Warburg Pincus XII, L.P. (“WP XII GP”), general partner of the WP XII Funds

    9. WP Global LLC (“WP Global”), general partner of WP XII GP

    10. Warburg Pincus Partners II, L.P. (“WPP II”), managing member of WP Global

    11. Warburg Pincus Partners II Holdings, L.P. (“WPP II Holdings”), a limited partner of WPP II

    12. Warburg Pincus Partners GP LLC (“WPP GP”), general partner of WPP II and WPP II Holdings

    13. Warburg Pincus & Co. (“WP”), managing member of WPP GP

     

    Item 2(b).

    Address of the Principal Business Office or, if None, Residence:

    For all Reporting Persons:

    450 Lexington Avenue

    New York, New York 10017, U.S.A.

     

    Item 2(c).

    Citizenship:

    See responses to Item 4 on each cover page.

     

    Item 2(d).

    Title of Class of Securities:

    Common Stock, $0.01 par value

     

    Item 2(e).

    CUSIP Number:

    01625V104

     

    Item 3.

    If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a(n):

    Not Applicable.


    Item 4.

    Ownership.

     

      (a)

    Amount beneficially owned:

    See response to Item 9 on each cover page.

     

      (b)

    Percent of Class:

    See response to Item 11 on each cover page.

     

      (c)

    Number of shares as to which the Reporting Person has:

     

      (i)

    Sole power to vote or to direct the vote:

     

       

    See responses to Item 5 on each cover page.

     

      (ii)

    Shared power to vote or to direct the vote: See responses to Item 6 on each cover page.

     

      (iii)

    Sole power to dispose or to direct the disposition of:

     

       

    See responses to Item 7 on each cover page.

     

      (iv)

    Shared power to dispose or to direct the disposition of:

     

       

    See responses to Item 8 on each cover page.

    WP XII directly holds 6,520,185 shares of Common Stock, WP XII-B directly holds 1,308,166 shares of Common Stock, WP XII-D directly holds 188,182 shares of Common Stock, WP XII-E directly holds 1,074,026 shares of Common Stock, WP XII Partners directly holds 351,766 shares of Common Stock, and Warburg Pincus XII Partners directly holds 680,454 shares of Common Stock.

    WP LLC is a registered investment adviser and the manager of the WP XII Funds, WP XII GP is the general partner of the WP XII Funds, WP Global is the general partner of WP XII GP, WPP II is the managing member of WP Global, WPP II Holdings is a limited partner of WPP II, WPP GP is the general partner of WPP II and WPP II Holdings, and WP is the managing member of WPP GP. Accordingly, each of the above may be deemed to have beneficial ownership over the 10,122,779 shares of Common Stock held by WP XII Funds, constituting 5.28% of the Issuer’s outstanding Common Stock. Investment and voting decisions by each of the foregoing with respect to such shares of Common Stock are made by a committee comprised of three or more individuals and all members of such committee disclaim beneficial ownership of the reported securities. The reported securities give effect to sales of securities made by the Reporting Persons between September 30, 2024 and the filing date hereof.

    All calculations of percentage ownership are based on 191,696,093 shares of Common Stock outstanding as of October 24, 2024, as reported on the Issuer’s Form 10-Q for the quarterly period ended September 30, 2024 filed on October 29, 2024.

    This filing of this Statement shall not be construed as an admission that any of the Reporting Persons are, for the purpose of Section 13(d) or 13(g) of the Exchange Act, the beneficial owner of any securities covered by this Statement.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    Not Applicable.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not Applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not Applicable.


    Item 8.

    Identification and Classification of Members of the Group.

    Not Applicable.

     

    Item 9.

    Notice of Dissolution of Group.

    Not Applicable.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: November 14, 2024

     

    Warburg Pincus Private Equity XII, L.P.
    By:   Warburg Pincus XII, L.P., its general partner
    By:   WP Global LLC, its general partner
    By:   Warburg Pincus Partners II, L.P., its managing member
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

      Name: Harsha Marti
      Title: Partner
    Warburg Pincus Private Equity XII-B, L.P.
    By:   Warburg Pincus XII, L.P., its general partner
    By:   WP Global LLC, its general partner
    By:   Warburg Pincus Partners II, L.P., its managing member
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

      Name: Harsha Marti
      Title: Partner
    Warburg Pincus Private Equity XII-D, L.P.
    By:   Warburg Pincus XII, L.P., its general partner
    By:   WP Global LLC, its general partner
    By:   Warburg Pincus Partners II, L.P., its managing member
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

      Name: Harsha Marti
      Title: Partner
    Warburg Pincus Private Equity XII-E, L.P.
    By:   Warburg Pincus XII, L.P., its general partner
    By:   WP Global LLC, its general partner
    By:   Warburg Pincus Partners II, L.P., its managing member
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

      Name: Harsha Marti
      Title: Partner


    WP XII Partners, L.P.
    By:   Warburg Pincus XII, L.P., its general partner
    By:   WP Global LLC, its general partner
    By:   Warburg Pincus Partners II, L.P., its managing member
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

      Name: Harsha Marti
      Title: Partner
    Warburg Pincus XII Partners, L.P.
    By:   Warburg Pincus XII, L.P., its general partner
    By:   WP Global LLC, its general partner
    By:   Warburg Pincus Partners II, L.P., its managing member
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

    By:   Name: Harsha Marti
      Title: Partner
    Warburg Pincus LLC
    By:  

    /s/ Harsha Marti

    By:   Name: Harsha Marti
      Title: Partner
    Warburg Pincus XII, L.P.
    By:   WP Global LLC, its general partner
    By:   Warburg Pincus Partners II, L.P., its managing member
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

    By:   Name: Harsha Marti
      Title: Partner
    WP Global LLC
    By:   Warburg Pincus Partners II, L.P., its managing member
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

    By:   Name: Harsha Marti
      Title: Partner


    Warburg Pincus Partners II, L.P.
    By:   Warburg Pincus Partners GP LLC, its general partner
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

    By:   Name: Harsha Marti
      Title: Partner
    Warburg Pincus Partners II Holdings, L.P.
    By:   Warburg Pincus & Co., its managing member
    By:  

    /s/ Harsha Marti

    By:   Name: Harsha Marti
      Title: Partner
    Warburg Pincus & Co.
    By:  

    /s/ Harsha Marti

    By:   Name: Harsha Marti
      Title: Partner


    EXHIBIT LIST

     

    Exhibit 1    Joint Filing Agreement dated as of February 14, 2022, incorporated herein by reference to Exhibit 1 of statement on Schedule 13G filed by the Reporting Persons on February 14, 2022.
    Get the next $ALHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALHC

    DatePrice TargetRatingAnalyst
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/30/2024$10.00Outperform
    Robert W. Baird
    5/30/2024$7.75 → $11.00Neutral → Buy
    BofA Securities
    5/8/2024$6.00 → $8.00Neutral → Overweight
    Piper Sandler
    3/6/2024$4.50Underweight
    Barclays
    3/6/2024$12.00 → $6.00Overweight → Neutral
    Piper Sandler
    1/24/2024$11.00Buy
    Stifel
    More analyst ratings

    $ALHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

      Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership, revenue, adjusted gross profit and adjusted EBITDARaises midpoint of outlook ranges for 2025 year-end membership, revenue, adjusted gross profit and adjusted EBITDA, supported by strong first-quarter clinical performance and enrollment growth momentumAnnounces transition of Thomas Freeman from Chief Financial Officer (CFO) to Strategic Advisor to the CEO; names finance veteran Jim Head as CFO ORANGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reporte

      5/1/25 4:01:00 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare to Present at the BofA Securities Healthcare Conference

      ORANGE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today announced that it will present at the BofA Securities Healthcare Conference on Wednesday, May 14, at 2:20 p.m. PDT. A webcast and replay of the presentations will be available on Alignment's investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ:ALHC), Alignment Health's mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day.

      4/28/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Strengthens Leadership to Scale its AI-Enabled Medicare Advantage Platform with Two Key Appointments

      ORANGE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced pivotal leadership appointments that underscore its dedication to transforming senior health care through technology and exceptional member care. Dr. Arta Bakshandeh has been named President of AVA®, and Aly Duzich has been promoted to Chief Experience Officer. Driving Next-Generation InnovationFor more than 10 years, Alignment has harnessed trusted artificial intelligence (AI) through AVA – the company's proprietary Medicare Advantage platform – to drive actionable clinical insights that improve senior health outcomes and quality of care. Dr. Bakshandeh's appointment reinforces Ali

      4/15/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    SEC Filings

    See more
    • SEC Form 144 filed by Alignment Healthcare Inc.

      144 - Alignment Healthcare, Inc. (0001832466) (Subject)

      5/1/25 4:50:50 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by Alignment Healthcare Inc.

      10-Q - Alignment Healthcare, Inc. (0001832466) (Filer)

      5/1/25 4:30:48 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Alignment Healthcare, Inc. (0001832466) (Filer)

      5/1/25 4:01:09 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alignment Healthcare upgraded by Stephens with a new price target

      Stephens upgraded Alignment Healthcare from Equal-Weight to Overweight and set a new price target of $17.00 from $13.00 previously

      12/3/24 7:13:50 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • KeyBanc Capital Markets initiated coverage on Alignment Healthcare

      KeyBanc Capital Markets initiated coverage of Alignment Healthcare with a rating of Sector Weight

      10/11/24 7:29:52 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Robert W. Baird initiated coverage on Alignment Healthcare with a new price target

      Robert W. Baird initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $10.00

      5/30/24 7:29:29 AM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      3/18/24 5:27:36 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Financials

    Live finance-specific insights

    See more
    • Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

      Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership, revenue, adjusted gross profit and adjusted EBITDARaises midpoint of outlook ranges for 2025 year-end membership, revenue, adjusted gross profit and adjusted EBITDA, supported by strong first-quarter clinical performance and enrollment growth momentumAnnounces transition of Thomas Freeman from Chief Financial Officer (CFO) to Strategic Advisor to the CEO; names finance veteran Jim Head as CFO ORANGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reporte

      5/1/25 4:01:00 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025

      ORANGE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its first quarter 2025 financial results on Thursday, May 1, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/frtkwokr A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will

      4/11/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance

      Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating leverage and strong medical benefits ratio performanceRaises midpoint of 2025 health plan membership guidance by 2,000 to reflect strong open enrollment period momentumIntroduces 2025 revenue guidance of $3.72 billion to $3.78 billion, representing 37.6%-39.6% growth year-over-year, and adjusted EBITDA of $35 million to $60 million ORANGE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its fourth quarter and full y

      2/27/25 4:01:00 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Head James M

      3 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      5/2/25 4:38:49 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Chief Legal and Admin. Officer Joyce Christopher J sold $421,828 worth of shares (25,000 units at $16.87), decreasing direct ownership by 6% to 390,022 units (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      5/2/25 4:29:30 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • President Maroney Dawn Christine sold $4,392,195 worth of shares (230,000 units at $19.10), decreasing direct ownership by 10% to 2,132,899 units (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      4/16/25 5:04:00 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Alignment Healthcare Appoints Sebastian Burzacchi to New Role of Chief Operating Officer of Management Services Organization and Andreas Wagner to Chief People Officer

      ORANGE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Sebastian Burzacchi will join as the new chief operating officer of its management services organization (MSO), and Andreas Wagner will serve as chief people officer, effective immediately. Sebastian Burzacchi, Chief Operating Officer of MSOReporting to Alignment founder and CEO John Kao, Sebastian Burzacchi will direct initiatives that strengthen a core value of the company – supporting doctors. This includes a focus on enhancing provider partnerships and ensuring a seamless experience for doctors with Alignment. "We are thrilled to welcome Sebastian to our leadership team, br

      1/9/24 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Health Welcomes New Chief People Officer as It Scales to Serve More Seniors Nationwide

      ORANGE, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- Alignment Health — a consumer brand name of Alignment Healthcare, Inc. (NASDAQ:ALHC), a tech-enabled Medicare Advantage company — today announced the appointment of Melinda Kimbro as its new chief people officer. Kimbro joined on June 30 to lead the company's human resources (HR) function and will oversee all aspects of the Alignment employee experience, including talent acquisition, culture, diversity, equity and inclusion, total rewards, and facilities. She will also spearhead the strategic development of internal talent to help further drive innovation and provide rich, ongoing career growth opportunities for employees. "Championing ou

      7/6/23 8:00:00 AM ET
      $ALHC
      $VSAT
      Medical Specialities
      Health Care
      Radio And Television Broadcasting And Communications Equipment
      Technology
    • Alignment Health Appoints 3 New Executives to Further Drive Strategic Growth Nationally

      ORANGE, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Alignment Health, a consumer brand name of Alignment Healthcare, Inc. (NASDAQ:ALHC), a tech-enabled Medicare Advantage (MA) company, is strengthening its sales team with the addition of three executives who will help propel the company's nationwide growth as it champions a new path in senior care. Appointed as Health Plan Chief Growth Officer, Todd Macaluso will lead the company's health plan growth by increasing net membership and improving the overall experience, execution, research and development efforts. David Milligan and Joe Kanatzar will serve as senior vice presidents of sales for California and all states outside California, resp

      6/6/23 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/14/24 5:57:27 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/14/24 1:28:35 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/12/24 1:26:14 PM ET
      $ALHC
      Medical Specialities
      Health Care